In June 2016 Dan Dalton was named Senior Vice President and Chief Compliance Officer of Avanir Pharmaceuticals.
Dan came to Avanir with more than 25 years of experience working with biopharmaceutical and medical device companies. He brings significant experience advising commercialization-stage biopharmaceutical companies. After practicing law at a major Philadelphia-based national law firm, Dan spent 18 years at Merck & Co. where he held several senior-level legal positions supporting Merck’s U.S.-based pharmaceutical and vaccine business. Dan has also served as Chief Compliance Officer for Salix Pharmaceuticals and Hill-Rom Holdings.
Dan earned a Juris Doctorate from the University of Pennsylvania Law School and a Bachelor of Science and Master of Business Administration from Lehigh University.